BCMA-directed cell therapy can offer a targeted mechanism of action that modulates myasthenia gravis pathology, Vu noted.

Chronic graft-vs-host disease (GVHD) is a cause of late morbidity and mortality after allogeneic stem cell transplant. During ...

The drug, dubbed ianalumab, both depletes B cells and deactivates those remaining, Thomas Grader-Beck, MD, of Johns Hopkins ...

The current recommended urine protein to creatinine ratio is arbitrary, and a lower bar would capture more lupus nephritis onset, researchers say. They make a case for changing the guidelines.

At week 52 in a randomized, controlled trial, results suggest that tocilizumab is more effective than methotrexate in ...

Patients who depended on oral corticosteroids to care for their severe asthma experienced improvements in asthma control ...

A 56-year-old man was admitted to the hospital because of left lower abdominal pain and anemia. He had a 1-year history of ...

Takeda ( TSE:4502/NYSE:TAK) announced the completion of the 7-year pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial evaluating its dengue vaccine, QDENGA ® ▼(Dengue ...

Objective: To describe the joint manifestations associated with clonal haematopoiesis and to compare patients with and ...

One man shares how his life and work were upended before finally getting answers. Learn about new treatments are helping patients regain control and improve quality of life. Myasthenia gravis is ...

Johnson & Johnson (NYSE:JNJ) today announced the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) as a single agent treatment for adult patients ...

A new option is now approved to treat adults living with high-risk smoldering multiple myeloma (MM). 1 The FDA has greenlit ...